COMPANY

GlycoScientific

HQ: Athens, GA source · glycoscientific.com ↗ · Southeast

Service / Tools company

Keywords: research tools

Location: Athens, GA · source · Oct 14, 2026

Profile checked Oct 10, 2026

18NIH grants

NIH awards 18

Annual award amounts. Total $5.5M.

Jun 14, 2023 NIH award 1R43HL166086-01A1 FY2023: $275,767 awarded for that fiscal year; activity R43 (SBIR); PI POPOV, MARLA; recipient as written: GLYCOSCIENTIFIC, LLC, ATHENS, GA. Recognition of O-GlcNAc Modified Proteins Using source ↗
2023 NIH contract (government contract; not a grant and not an investment round) 75N93023C00038-0-9999-1 FY2023: $600,000 awarded for that fiscal year; activity N43 (OTHER_NIH); PI POPOV, MARLA; recipient as written: GLYCOSCIENTIFIC, LLC, ATHENS, GA. Development of source ↗
Jan 29, 2021 NIH award 5R42GM113666-03 FY2021: $344,451 awarded for that fiscal year; activity R42 (STTR); PI ORLANDO, RON; recipient as written: GLYCOSCIENTIFIC, LLC, ATHENS, GA. Development of Isotopically Labeled Glycoproteins source ↗
Aug 28, 2020 NIH award 1R41GM139440-01 FY2020: $252,114 awarded for that fiscal year; activity R41 (STTR); PI ORLANDO, RON; recipient as written: GLYCOSCIENTIFIC, LLC, ATHENS, GA. Isotopically Labeled Heparan Sulfate Glycosaminog source ↗
Apr 28, 2020 NIH award 5R43GM133288-02 FY2020: $148,483 awarded for that fiscal year; activity R43 (SBIR); PI POPOV, MARLA; recipient as written: GLYCOSCIENTIFIC, LLC, ATHENS, GA. Development of Site-specific Arg-GlcNAc Antibodie source ↗
Jan 14, 2020 NIH award 2R42GM113666-02 FY2020: $352,644 awarded for that fiscal year; activity R42 (STTR); PI ORLANDO, RON; recipient as written: GLYCOSCIENTIFIC, LLC, ATHENS, GA. Development of Isotopically Labeled Glycoproteins source ↗
May 2, 2019 NIH award 1R43GM133288-01 FY2019: $150,000 awarded for that fiscal year; activity R43 (SBIR); PI POPOV, MARLA; recipient as written: GLYCOSCIENTIFIC, LLC, ATHENS, GA. Development of Site-specific Arg-GlcNAc Antibodie source ↗
Apr 9, 2019 NIH award 5R44GM110887-04 FY2019: $350,000 awarded for that fiscal year; activity R44 (SBIR); PI POPOV, MARLA; recipient as written: GLYCOSCIENTIFIC, LLC, ATHENS, GA. Development of Site-specific O-GlcNAc Antibodies source ↗
2019 NIH contract (government contract; not a grant and not an investment round) 75N93019C00048-0-9999-1 FY2019: $653,191 awarded for that fiscal year; activity N43 (OTHER_NIH); PI ORLANDO, RON; recipient as written: GLYCOSCIENTIFIC, LLC, ATHENS, GA. CREATING ANTIB source ↗
Aug 20, 2018 NIH award 3R44GM110887-03S1 FY2018: $60,832 awarded for that fiscal year; activity R44 (SBIR); PI POPOV, MARLA; recipient as written: GLYCOSCIENTIFIC, LLC, ATHENS, GA. Development of Site-specific O-GlcNAc Antibodies source ↗
Apr 23, 2018 NIH award 5R44GM110887-03 FY2018: $350,000 awarded for that fiscal year; activity R44 (SBIR); PI POPOV, MARLA; recipient as written: GLYCOSCIENTIFIC, LLC, ATHENS, GA. Development of Site-specific O-GlcNAc Antibodies source ↗
May 1, 2017 NIH award 2R44GM110887-02 FY2017: $349,999 awarded for that fiscal year; activity R44 (SBIR); PI POPOV, MARLA; recipient as written: GLYCOSCIENTIFIC, LLC, ATHENS, GA. Development of Site-specific O-GlcNAc Antibodies source ↗
Sep 26, 2016 NIH award 1R41GM119879-01A1 FY2016: $242,306 awarded for that fiscal year; activity R41 (STTR); PI ORLANDO, RON; recipient as written: GLYCOSCIENTIFIC, LLC, ATHENS, GA. Generation of antibodies to monitor Notch O-fuc source ↗
Dec 24, 2014 NIH award 1R41GM113666-01 FY2015: $270,251 awarded for that fiscal year; activity R41 (STTR); PI ORLANDO, RON; recipient as written: GLYCOSCIENTIFIC, LLC, ATHENS, GA. Development of Isotopically Labeled Glycoproteins source ↗
Jun 27, 2014 NIH award 1R43GM110887-01 FY2014: $349,180 awarded for that fiscal year; activity R43 (SBIR); PI HARVEY, ALEX JORDAN; recipient as written: GLYCOSCIENTIFIC, LLC, ATHENS, GA. Antibodies to O-GlcNAc modified histones f source ↗
Sep 20, 2013 NIH award 5R41GM104631-02 FY2013: $301,575 awarded for that fiscal year; activity R41 (STTR); PI ORLANDO, RON; recipient as written: GLYCOSCIENTIFIC, LLC, ATHENS, GA. Site-specific O-GlcNAc MAbs: New Tools for Glyco source ↗
Sep 17, 2012 NIH award 1R41GM104631-01 FY2012: $322,669 awarded for that fiscal year; activity R41 (STTR); PI ORLANDO, RON; recipient as written: GLYCOSCIENTIFIC, LLC, ATHENS, GA. Site-specific O-GlcNAc MAbs: New Tools for Glyco source ↗
2011 NIH contract (government contract; not a grant and not an investment round) 261201100074C-0-0-1 FY2011: $149,951 awarded for that fiscal year; activity N43 (OTHER_NIH); PI HINES, MARIA; recipient as written: GLYCOSCIENTIFIC, LLC, ATHENS, GA. SBIR TOPIC 294 PHA source ↗